The Federal Trade Commission won’t challenge Amazon’s (AMZN) deal to buy One Medical parent 1Life Healthcare (ONEM), meaning the deal could close later this week, reported Bloomberg’s Leah Nylen, citing people familiar with the matter.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ONEM:
- Why did 1Life Healthcare (NASDAQ:ONEM) Stock Rise Pre-Market?
- One Medical Announces Results for Fourth Quarter and Full Year 2022
- 1Life Healthcare rallies, shares up 4% to $16.00
- 1Life, iRobot deals could be included in Amazon FTC case, Bloomberg says
- 1Life dips after WSJ says FTC considering antitrust suit against Amazon
